Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-31

FDA Approved: BENZONATATE — Original Application (TAGI Pharma, Inc.)

View source ↗

Summary

The FDA approved TAGI Pharma, Inc.'s original application for benzonatate, establishing the availability of this generic cough suppressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzonatate (BENZONATATE)

Snippet

ORIG AP for BENZONATATE (BENZONATATE)